Received by email:

File: 2018-05-29_Signs MOU.DOCX

SPEAKEASY CANNABIS CLUB LTD.
Suite 800-1199 West Hastings Street, Vancouver, BC V6E 3T5
T 604-283-1722
F 888-241-5996
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES
For Immediate Release        May 29, 2018

SpeakEasy Signs a MOU to Bring Premium Cannabis to Germany and the European Union with HerbaMedica GmbH

Vancouver, B.C., - Speakeasy Cannabis Club Ltd. (CSE: EASY) (Frankfurt: 39H) (the "Company" or "SpeakEasy") a late sta
--->ge ACMPR applicant is pleased to announce it has signed a memorandum of understanding with HerbaMedica GmbH to export 
--->premium cannabis to Germany and the EU markets.
HerbaMedica will buy/distribute a fixed amount of products from SpeakEasy and SpeakEasy will provide this amount every
---> year, initially this obligation shall last for three years after the binding conclusion of the Venture. binding concl
--->usion of the Venture. The before mentioned amount shall be fixed between the parties once the German authorities have 
--->granted the license, companies will engage in signing a definitive agreement, with further in-depth details being prov
--->ided, independent from the allowed amounts according to that license. In the before mentioned period of initially thre
--->e years Partner will only distribute or sell Products to or in Germany and the EU via HerbaMedica. "By having HerbaMed
--->ica distribute our products throughout the EU, we gain access to a significant amount of possible clientele. Currently
---> there are only 7 approved Cannabis importers to Germany, Speakeasy is excited to be a applicant for this opportunity 
--->to join this group of selected few.
HerbaMedica plans to give SpeakEasy access to the German and EU market (to the extent that the latter is included in t
--->he access to the German market) with applying and paying for their inspection. The inspection will consist of two stag
--->es. Initially a specialised Consulting Company regarding the EU GMP (Good Manufacturing Practice) and EU GACP (Good Ag
--->ricultural Cultivation Practice) will inspect the sites and advise on necessary improvements / changes to receive the 
--->EU license. Thereafter the sites will be inspected by the competent German authorities. Theexternal costs for the insp
--->ection will be borne by HerbaMedica, internal preparation / improvement costs of SpeakEasy will remain with the SpeakE
--->asy. 
 "SpeakEasy is a great fit for Herba Medica because of the extensive knowledge Marc and his team bring to the table in
---> all facets of the cannabis industry. Both our companies specialties are very complimentary to each other." - Stated H
--->erbaMedica CEO David Hohne
About HerbaMedica: 
HerbaMedica is late stage applicant for importing cannabis into Germany. It was founded in Summer 2017 to become a imp
--->orter of premium cannabis flower and cannabis based products to Germany and the European Union. Currently there are se
--->ven importers which are all importing from the same sources into the German market.



ON BEHALF OF SPEAKEASY CANNABIS CLUB LTD. 
(signed) "Marc Geen"
Chief Executive Officer 
For further information, please contact: 
Speakeasy Cannabis Club Ltd. www.speakeasygrowers.com Telephone: 604-283-1722   Not for distribution to United States 
--->wire services or dissemination in the United States. This news release does not constitute an offer to sell or a solic
--->itation of an offer to buy any of the securities in the United States. The securities have not been and will not be re
--->gistered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securitie
--->s laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Sec
--->urities Act and applicable state securities laws or an exemption from such registration is available. 
Certain statements included in this press release constitute forward-looking information or statements (collectively, 
--->"forward-looking statements"), including those identified by the expressions "anticipate", "believe", "plan", "estimat
--->e", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its manage
--->ment. The forward-looking statements are not historical facts but reflect current expectations regarding future result
--->s or events. This press release contains forward looking statements. These forward-looking statements are based on cur
--->rent expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties an
--->d other factors.
Statements about the Target's future facility expansion plans or ACMPR license application are all forward-looking inf
--->ormation.
Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions w
--->hich are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-
--->looking statements include failure to obtain regulatory approval, the continued availability of capital and financing,
---> and general economic, market or business conditions. Forward-looking statements contained in this press release are e
--->xpressly qualified by this cautionary statement. These statements should not be read as guarantees of future performan
--->ce or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual 
--->results, performance or achievements to be materially different from those implied by such statements. Although such s
--->tatements are based on management's reasonable assumptions, there can be no assurance that the statements will prove t
--->o be accurate or that management's expectations or estimates of future developments, circumstances or results will mat
--->erialize. The Company assumes no responsibility to update or revise forward-looking information to reflect new events 
--->or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking stat
--->ements. 
Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in 
--->the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.